As a paradigm for the future, micro-scale technology seeks to fuse revolutionary concepts in science and engineering and then translate it into reality. Nanotechnology is an interdisciplinary field that aims to connect what is seen with the naked eye and what is unseen on the molecular level.

The Handbook of Research on Diverse Applications of Nanotechnology in Biomedicine, Chemistry, and Engineering examines the strengths and future potential of micro-scale technologies in a variety of industries. Highlighting the benefits, shortcomings, and emerging perspectives in the application of nano-scale technologies, this book is a comprehensive reference source for synthetic chemists, engineers, graduate students, and researchers with an interest in the multidisciplinary applications, as well as the ongoing research in the field.

Coverage:

The many academic areas covered in this publication include, but are not limited to:

Nanogenomics
Nanomechanics
Nanomedicine
Nanotoxicology
Regenerative Medicine
System Biology
Tissue Engineering

Reviews & Statements

Contributors in the various disciplines and professions describe applications of nanotechnology in them. After introductory chapters reviewing nanotechnology itself, they cover diagnostic and therapeutic tools for diseases; tissue engineering and regenerative medicine; nano-sensors, environmental remediation, and forensic science; mathematical modeling and systems biology; and nano-science and engineering. Among the topics are phage biotechnology, managing respiratory disease, next-generation biofuels, functionalized magnetic nanoparticles for environmental remediation, and nanocomposites for surface coating.

– ProtoView Book Abstracts (formerly Book News, Inc.)

Table of Contents

Search this Book:

Reset

Editor/Author Biographies

Shivani Soni joined as an assistant professor in Department of Biological sciences in April 2010.Dr. Soni obtained her Bachelor’s and Master’s degrees in Zoology from University of Delhi, India. She received her postdoctoral training with Dr. Manjit Hanspal at Tufts School of Medicine, Boston, Massachusetts. Later, she joined as a senior postdoctoral fellow in Dr. Shiladitya Sengupta's lab at Health Science and Technology division of Harvard Medical School-MIT, Boston, Massachusetts. Her research interests are in the area of Hematology and Oncology. Her research has focused in the field of erythropoesis (red blood cell formation), where she demonstrated the role of a novel protein Emp (Erythroblast Macrophage Protein) in red blood cells and macrophage development. Emp was discovered by Dr. Hanspal in 1994, and Dr. Soni was the first one to characterize its function in vivo in 2006. This has resulted in multiple high impact publications and a prestigious travel award from American Society of Hematology. Additionally, she had also explored events preceding the release of malarial parasite from RBCs as an extension of her PhD work. Her current research focuses on developing strategies that can be applied into clinico-pathological conditions related to abnormal erythropoiesis, cell-to-cell adhesion and migration. Another part of her research in the area of Oncology involves engineering concepts pertaining to biological systems. In collaboration, she has developed several novel polymeric hybrid nanoformulations for cancer chemotherapy and targeting aberrant signal transduction pathways, which has led to many publications in peer reviewed journals as well as patents. Dr. Soni is the reviewer of many journals related to Hematology, Oncology, and Biochemistry. She received her PhD degree from University of Delhi in Molecular Parasitology, focusing on development of drug resistance in malarial parasites and their transmission. Her lab is a platform for inculcating basic research aptitude in undergraduate and graduate students of minority background.

Amandeep Salhotra is currently working as an Assistant Professor at the Department of Hematology and Hematopoietic Cell Transplantation at City of Hope National Medical Center. His area of interest is in treating patients with hematologic malignancies and improving outcomes in patients post Allogeneic Hematopoietic Cell Transplantation by reducing morbidity associated with acute and chronic graft versus host disease. He completed his basic medical training from Maulana Azad Medical College in New Delhi, India and subsequently spent a couple of years at Johns Hopkins University doing translational research focusing primarily on molecular pathogenesis of Glioblastoma multiforme and novel imaging techniques using Nuclear Magnetic Resonance (NMR). His current focus is running Phase I/II clinical trials for patients with hematologic disorders on to improve their clinical outcomes, especially in the relapsed/refractory setting. Outside of the academic setting, he enjoys spending time with his family and visiting new places.

Mrutyunjay Suar is a Professor and Director of the School of Biotechnology at KIIT University, India. He also currently serves as the CEO of Technology Business Incubator and Director R&D cell at KIIT University. He received the degree of MSc from Goa University, India in 1999 and PhD in Molecular Biology from the University of Delhi, India in 2003. Thereafter, he worked at Institute of Microbiology, ETH Zurich, Switzerland, until 2007, as post-doctoral fellow. He has been a visiting fellow at several prestigious institutions such as UCLA (USA), EPFL & EAWAG (Switzerland), UC-Berkley (USA). His research interests centre on developing a recombinant safe mucosal vaccine candidate against enterocolitic pathogens using Salmonella typhimurium as a model organism. He has also explored the differential virulence properties of Salmonella typhimurium and Salmonella enteritidis. His research is mostly translational in nature and he believes in developing platform technologies for common man, which are sustainable and user friendly. He has published 30 research articles in international peer-reviewed journals and promoting 7 start up companies in the areas of biotechnology and engineering.

Abstracting & Indexing

Archiving

All of IGI Global's content is archived via the CLOCKSS and LOCKSS initiative. Additionally, all IGI Global published content is available in IGI Global's InfoSci^® platform.